Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. - Wikidata - wikimedia - TriplyDB

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.

http://www.wikidata.org/entity/Q34594429

about

Primary biliary cirrhosis Autoimmune liver serology: current diagnostic and clinical challenges Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists The diagnosis of primary biliary cirrhosis Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis Primary biliary cirrhosis and the nuclear pore complex.Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods Autoantibodies and liver disease: uses and abuses.Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis.Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients Early primary biliary cirrhosis: a new association with erythema nodosum of unknown origin.Primary biliary cirrhosis: what do autoantibodies tell us?Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients Antinuclear antibodies as ancillary markers in primary biliary cirrhosis.Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosis The autoimmunity of primary biliary cirrhosis and the clonal selection theory.Tracing environmental markers of autoimmunity: introducing the infectome.Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.Primary biliary cirrhosis: family stories Are dysregulated inflammatory responses to commensal bacteria involved in the pathogenesis of hepatobiliary-pancreatic autoimmune disease? An analysis using mice models of primary biliary cirrhosis and autoimmune pancreatitis.Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies.Popular and unpopular infectious agents linked to primary biliary cirrhosis.Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis.Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.Epstein-barr virus as a trigger of autoimmune liver diseases.Sex differences associated with primary biliary cirrhosis.Molecular diagnostic testing for primary biliary cholangitis.Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.Role of autoimmunity in primary biliary cirrhosis.Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis.Risk factors for hepatic decompensation in patients with primary biliary cirrhosis Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis.A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis.Etiopathogenesis of primary biliary cirrhosis.Natural history and management of primary biliary cirrhosis.

P2860

Q21202919-4971DA37-CBD5-42BD-9513-C011125DD5F1 Q24644140-DD9CC7E3-4113-4AE9-8084-C2814E90CF84 Q26766699-8FF23EB9-2007-4A5D-8842-8D520449F142 Q26796355-FFDF7C67-D795-469C-B8CE-267DCFE849EF Q26829493-D1F1C3A5-D401-4FAB-96A9-65B616045987 Q26992087-CA89AD1A-E39E-4AB0-9F8D-9E6440B3216A Q30415170-695B7F2B-830C-489F-9EFC-9690474CCFE7 Q33537502-AC69CD72-D29E-4D95-92FB-314BBDC974F9 Q33829963-04869C51-C96F-4474-BD32-98E3A20268EB Q33882608-E7DFB730-B0A8-426D-A4C8-79FC21CD01DC Q33912324-F5493232-799F-4004-91E2-B153722003E1 Q34034216-7AF4B967-4B8B-4668-B232-88C326C1A15B Q34041388-CF0037AA-DCAF-4C81-A122-3478CB3D75A0 Q34213743-BA457DA1-58EF-4DBE-BDF1-EB3310B4EB7C Q34237440-03B13BDA-D423-45F7-BFBC-D834D6EC8E55 Q34341006-03B6BECC-7C36-4D4B-B308-80E13E982395 Q34472336-EE147B8C-61D2-444E-AF8A-5D15F4062C47 Q34671373-8ECC6E06-158D-44B4-8864-E417AA033E5B Q34827471-6682A5F3-05C0-417E-BB68-5F7AA0194E4A Q35038800-1334C51D-BEFE-40C5-98F5-85FC0E4DC2C6 Q35200720-B6B68046-D942-4D04-BB80-69571B6A37EC Q35309080-40541569-CFEB-400F-A236-74D157E15FBC Q35309854-40DAEC9B-22F7-456A-95F7-253470DF883F Q35309882-C51E0857-774F-4453-B572-C2EF4E9E4EC9 Q35309953-B608A692-5968-4A99-8E08-8EB9BC54DB37 Q35609106-B4AD64D9-A070-448C-94CD-5C807D4691F5 Q36010920-19CCBC65-871C-4FE6-9409-AA57B2D72A58 Q36014535-FD913E2A-DF24-4CEA-84B6-BE759CF39997 Q36086498-E92A9627-D6D8-429D-9FD9-52D6FC7B21EE Q36211824-6F7911E0-3BFF-4F72-B9A0-DDE899601C2F Q36233851-3E279AEB-0654-4454-9B7F-3558E9EBCC3B Q36529131-C016A527-0B50-4794-AF02-902C1643A5E8 Q36599248-44AFD726-4262-4599-8B60-97AE28E569B3 Q36637728-08C11976-D949-4686-A741-0CB395E6436C Q36752084-FE1F6EAB-40AB-4017-B5C0-82844A3DF734 Q36848255-CB38FA18-2D19-47F8-BB62-7FA5C8DC3304 Q36963978-A091B12F-BBDD-4679-A75B-2E002D6E2E3D Q37135580-EC19C295-F468-4E5D-B866-865EA33D7A01 Q37182941-3C1A6A69-2D91-412F-B5E5-79F51F4EEA8F Q37355843-BF080EFD-6BC9-4239-B445-AC4C3E915D9F

P2860

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.

http://www.wikidata.org/entity/Q34594429

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@ast

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@en

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@nl

type

label

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@ast

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@en

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@nl

prefLabel

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@ast

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@en

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@nl

P1433

Q34594429-5ED8B6AE-FE0E-4BF8-860E-D57E110EC6D1

P1476

Q34594429-98FD7BC6-FF45-4B94-8772-CEA7541F83DF

P2093

Q34594429-102CB29A-64EA-4AB4-BDAD-62E084E2B2BB

Q34594429-196ADE06-0939-400A-A1F3-76328967F685

Q34594429-1B1CB2CD-9079-4017-9567-FD3A9BCFE912

Q34594429-1D8998D0-12A2-4A60-BACE-8217422251FF

Q34594429-1F2A44F9-76F7-4B54-BE71-1EA0BE55C0BD

Q34594429-286FEA9B-0235-4CF0-AA56-A13FC10549EA

Q34594429-2CAD7FD6-FCDA-47DD-82E1-92662C73C930

Q34594429-3456F14F-D46A-4822-A349-EEBA7C09681B

Q34594429-35C5EAEC-B867-4D18-8DF7-7FFF86E74A13

Q34594429-39BA0467-E969-4545-BCD3-7575CE3109CB

P304

Q34594429-7C950BD9-3659-410B-A7C8-E3B24DFB5469

P31

Q34594429-E298A65A-4FA3-4CF8-BE6E-EA3202FC06E8

P356

Q34594429-A707DE9C-B2BA-4D73-AE63-DAB0B6B9C608

P407

Q34594429-C1FC8619-0097-48B1-8FB3-69D738DE074F

P433

Q34594429-5A507589-A418-41AF-8D5C-18636EEA6835

P478

Q34594429-B30E7198-FDE7-4A78-A596-97F3C9794A29

P577

Q34594429-31DF33E6-93E0-496F-A1B6-CD277C515D80

P698

Q34594429-9F2DA45D-9AE8-43B8-B60B-AAF138DF3D16

P921

Q34594429-156F5A9E-CBB3-4385-90F9-F7682611B8E4

P356

P1433

P1476

Anti-gp210 and anti-centromere ...... of primary biliary cirrhosis.

@en

P2093

Akihide Masumoto

http://www.w3.org/2001/XMLSchema#string

Akira Saito

http://www.w3.org/2001/XMLSchema#string

Atsumasa Komori

http://www.w3.org/2001/XMLSchema#string

Eiichi Takezaki

http://www.w3.org/2001/XMLSchema#string

Gary L Norman

http://www.w3.org/2001/XMLSchema#string

Hideharu Harada

http://www.w3.org/2001/XMLSchema#string

Hidehiro Nishi

http://www.w3.org/2001/XMLSchema#string

Hiromi Ishibashi

http://www.w3.org/2001/XMLSchema#string

Hironori Sakai

http://www.w3.org/2001/XMLSchema#string

Hiroshi Adachi

http://www.w3.org/2001/XMLSchema#string

P304

118-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21472

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17187436

http://www.w3.org/2001/XMLSchema#string

P921